|
1
|
Wiedemann HR: Guido Fanconi (1892-1979) in
memoriam. Eur J Pediatr. 132:131–132. 1979.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Mehta PA and Tolar J: Fanconi Anemia. In:
GeneReviews®. Adam MP, Ardinger HH, Pagon RA, et
al (eds). University of Washington, Seattle, WA, 2002.
|
|
3
|
Keefe P and Bokhari SRA: Fanconi Syndrome.
In: StatPearls. StatPearls Publishing, Treasure Island, FL,
2021.
|
|
4
|
Bagby GC: Multifunctional Fanconi
proteins, inflammation and the Fanconi phenotype. EBioMedicine.
8:10–11. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Tipping AJ, Pearson T, Morgan NV, Gibson
RA, Kuyt LP, Havenga C, Gluckman E, Joenje H, de Ravel T, Jansen S,
et al: Molecular and genealogical evidence for a founder effect in
Fanconi anemia families of the Afrikaner population of South
Africa. Proc Natl Acad Sci USA. 98:5734–5739. 2001.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Strom CM, Crossley B, Redman JB, Quan F,
Buller A, McGinniss MJ and Sun W: Molecular screening for diseases
frequent in Ashkenazi Jews: Lessons learned from more than 100,000
tests performed in a commercial laboratory. Genet Med. 6:145–152.
2004.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Callén E, Casado JA, Tischkowitz MD,
Bueren JA, Creus A, Marcos R, Dasí A, Estella JM, Muñoz A, Ortega
JJ, et al: A common founder mutation in FANCA underlies the world's
highest prevalence of Fanconi anemia in Gypsy families from Spain.
Blood. 105:1946–1949. 2005.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Rosenberg PS, Tamary H and Alter BP: How
high are carrier frequencies of rare recessive syndromes?
Contemporary estimates for Fanconi Anemia in the United States and
Israel. Am J Med Genet A. 155A:1877–1883. 2011.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Shimamura A and Alter BP: Pathophysiology
and management of inherited bone marrow failure syndromes. Blood
Rev. 24:101–122. 2010.PubMed/NCBI View Article : Google Scholar
|
|
10
|
D'Andrea AD: The Fanconi road to cancer.
Genes Dev. 17:1933–1936. 2003.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Niraj J, Färkkilä A and D'Andrea AD: The
Fanconi Anemia Pathway in Cancer. Annu Rev Cancer Biol. 3:457–478.
2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Ceccaldi R, Sarangi P and D'Andrea AD: The
Fanconi anaemia pathway: New players and new functions. Nat Rev Mol
Cell Biol. 17:337–349. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Meetei AR, Levitus M, Xue Y, Medhurst AL,
Zwaan M, Ling C, Rooimans MA, Bier P, Hoatlin M, Pals G, et al:
X-linked inheritance of Fanconi anemia complementation group B. Nat
Genet. 36:1219–1224. 2004.PubMed/NCBI View
Article : Google Scholar
|
|
14
|
Ameziane N, May P, Haitjema A, van de
Vrugt HJ, van Rossum-Fikkert SE, Ristic D, Williams GJ, Balk J,
Rockx D, Li H, et al: A novel Fanconi anaemia subtype associated
with a dominant-negative mutation in RAD51. Nat Commun.
6(8829)2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wang AT, Kim T, Wagner JE, Conti BA, Lach
FP, Huang AL, Molina H, Sanborn EM, Zierhut H, Cornes BK, et al: A
Dominant Mutation in Human RAD51 Reveals Its Function in DNA
Interstrand Crosslink Repair Independent of Homologous
Recombination. Mol Cell. 59:478–490. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Nalepa G and Clapp DW: Fanconi anaemia and
cancer: An intricate relationship. Nat Rev Cancer. 18:168–185.
2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Stone MP, Cho YJ, Huang H, Kim HY, Kozekov
ID, Kozekova A, Wang H, Minko IG, Lloyd RS, Harris TM, et al:
Interstrand DNA cross-links induced by alpha,beta-unsaturated
aldehydes derived from lipid peroxidation and environmental
sources. Acc Chem Res. 41:793–804. 2008.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Milletti G, Strocchio L, Pagliara D,
Girardi K, Carta R, Mastronuzzi A, Locatelli F and Nazio F:
Canonical and Noncanonical Roles of Fanconi Anemia Proteins:
Implications in Cancer Predisposition. Cancers (Basel).
12(2684)2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Che R, Zhang J, Nepal M, Han B and Fei P:
Multifaceted Fanconi Anemia Signaling. Trends Genet. 34:171–183.
2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Duxin JP and Walter JC: What is the DNA
repair defect underlying Fanconi anemia? Curr Opin Cell Biol.
37:49–60. 2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Singh TR, Saro D, Ali AM, Zheng XF, Du CH,
Killen MW, Sachpatzidis A, Wahengbam K, Pierce AJ, Xiong Y, et al:
MHF1-MHF2, a histone-fold-containing protein complex, participates
in the Fanconi anemia pathway via FANCM. Mol Cell. 37:879–886.
2010.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Shakeel S, Rajendra E, Alcón P, O'Reilly
F, Chorev DS, Maslen S, Degliesposti G, Russo CJ, He S, Hill CH, et
al: Structure of the Fanconi anaemia monoubiquitin ligase complex.
Nature. 575:234–237. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Smogorzewska A, Matsuoka S, Vinciguerra P,
McDonald ER III, Hurov KE, Luo J, Ballif BA, Gygi SP, Hofmann K,
D'Andrea AD, et al: Identification of the FANCI protein, a
monoubiquitinated FANCD2 paralog required for DNA repair. Cell.
129:289–301. 2007.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Mehta PA, Davies SM, Leemhuis T, Myers K,
Kernan NA, Prockop SE, Scaradavou A, O'Reilly RJ, Williams DA,
Lehmann L, et al: Radiation-free, alternative-donor HCT for Fanconi
anemia patients: Results from a prospective multi-institutional
study. Blood. 129:2308–2315. 2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Ebens CL, MacMillan ML and Wagner JE:
Hematopoietic cell transplantation in Fanconi anemia: Current
evidence, challenges and recommendations. Expert Rev Hematol.
10:81–97. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Krausz C, Riera-Escamilla A, Chianese C,
Moreno-Mendoza D, Ars E, Rajmil O, Pujol R, Bogliolo M, Blanco I,
Rodríguez I, et al: From exome analysis in idiopathic azoospermia
to the identification of a high-risk subgroup for occult Fanconi
anemia. Genet Med. 21:189–194. 2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Freire BL, Homma TK, Funari MFA, Lerario
AM, Leal AM, Velloso EDRP, Malaquias AC and Jorge AAL: Homozygous
loss of function BRCA1 variant causing a Fanconi-anemia-like
phenotype, a clinical report and review of previous patients. Eur J
Med Genet. 61:130–133. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Bianchi FT, Berto GE and Di Cunto F:
Impact of DNA repair and stability defects on cortical development.
Cell Mol Life Sci. 75:3963–3976. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Auerbach AD: Fanconi anemia and its
diagnosis. Mutat Res. 668:4–10. 2009.PubMed/NCBI View Article : Google Scholar
|
|
30
|
De Kerviler E, Guermazi A, Zagdanski AM,
Gluckman E and Frija J: The clinical and radiological features of
Fanconi's anaemia. Clin Radiol. 55:340–345. 2000.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Giampietro PF, Adler-Brecher B, Verlander
PC, Pavlakis SG, Davis JG and Auerbach AD: The need for more
accurate and timely diagnosis in Fanconi anemia: A report from the
International Fanconi Anemia Registry. Pediatrics. 91:1116–1120.
1993.PubMed/NCBI
|
|
32
|
Tercanli S, Miny P, Siebert MS, Hösli I,
Surbek DV and Holzgreve W: Fanconi anemia associated with increased
nuchal translucency detected by first-trimester ultrasound.
Ultrasound Obstet Gynecol. 17:160–162. 2001.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Schneider M, Chandler K, Tischkowitz M and
Meyer S: Fanconi anaemia: Genetics, molecular biology, and cancer -
implications for clinical management in children and adults. Clin
Genet. 88:13–24. 2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Risitano AM, Marotta S, Calzone R,
Grimaldi F and Zatterale A: RIAF Contributors. Twenty years of the
Italian Fanconi Anemia Registry: Where we stand and what remains to
be learned. Haematologica. 101:319–327. 2016.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Petryk A, Kanakatti Shankar R, Giri N,
Hollenberg AN, Rutter MM, Nathan B, Lodish M, Alter BP, Stratakis
CA and Rose SR: Endocrine disorders in Fanconi anemia:
Recommendations for screening and treatment. J Clin Endocrinol
Metab. 100:803–811. 2015.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Rose SR, Myers KC, Rutter MM, Mueller R,
Khoury JC, Mehta PA, Harris RE and Davies SM: Endocrine phenotype
of children and adults with Fanconi anemia. Pediatr Blood Cancer.
59:690–696. 2012.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Tamary H, Nishri D, Yacobovich J, Zilber
R, Dgany O, Krasnov T, Aviner S, Stepensky P, Ravel-Vilk S, Bitan
M, et al: Frequency and natural history of inherited bone marrow
failure syndromes: The Israeli Inherited Bone Marrow Failure
Registry. Haematologica. 95:1300–1307. 2010.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Río P, Navarro S, Wang W,
Sánchez-Domínguez R, Pujol RM, Segovia JC, Bogliolo M, Merino E, Wu
N, Salgado R, et al: Successful engraftment of gene-corrected
hematopoietic stem cells in non-conditioned patients with Fanconi
anemia. Nat Med. 25:1396–1401. 2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Rosenberg PS, Alter BP and Ebell W: Cancer
risks in Fanconi anemia: Findings from the German Fanconi Anemia
Registry. Haematologica. 93:511–517. 2008.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Kutler DI, Singh B, Satagopan J, Batish
SD, Berwick M, Giampietro PF, Hanenberg H and Auerbach AD: A
20-year perspective on the International Fanconi Anemia Registry
(IFAR). Blood. 101:1249–1256. 2003.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Savage SA and Walsh MF: Myelodysplastic
Syndrome, Acute Myeloid Leukemia, and Cancer Surveillance in
Fanconi Anemia. Hematol Oncol Clin North Am. 32:657–668.
2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Murillo-Sanjuán L, González-Vicent M,
Argilés-Aparicio B, Badell-Serra I, Rodríguez-Villa A,
Uria-Oficialdegui ML, López-Duarte M, Beléndez-Bieler C,
Sastre-Urgelles A, Sevilla-Navarro J, et al: Survival and toxicity
outcomes of hematopoietic stem cell transplantation for pediatric
patients with Fanconi anemia: a unified multicentric national study
from the Spanish Working Group for Bone Marrow Transplantation in
Children. Bone Marrow Transplant. 56:1213–1216. 2021.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Kutler DI, Patel KR, Auerbach AD, Kennedy
J, Lach FP, Sanborn E, Cohen MA, Kuhel WI and Smogorzewska A:
Natural history and management of Fanconi anemia patients with head
and neck cancer: A 10-year follow-up. Laryngoscope. 126:870–879.
2016.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Alter BP and Giri N: Thinking of
VACTERL-H? Rule out Fanconi Anemia according to PHENOS. Am J Med
Genet A. 170:1520–1524. 2016.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Furquim CP, Pivovar A, Amenábar JM, Bonfim
C and Torres-Pereira CC: Oral cancer in Fanconi anemia: Review of
121 cases. Crit Rev Oncol Hematol. 125:35–40. 2018.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Rosenberg PS, Greene MH and Alter BP:
Cancer incidence in persons with Fanconi anemia. Blood.
101:822–826. 2003.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Bremer M, Schindler D, Gross M, Dörk T,
Morlot S and Karstens JH: Fanconi's anemia and clinical
radiosensitivity report on two adult patients with locally advanced
solid tumors treated by radiotherapy. Strahlenther Onkol.
179:748–753. 2003.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Katzenellenbogen RA, Carter JJ, Stern JE,
Butsch Kovacic MS, Mehta PA, Sauter SL, Galloway DA and Winer RL:
Skin and mucosal human papillomavirus seroprevalence in persons
with Fanconi Anemia. Clin Vaccine Immunol. 22:413–420.
2015.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Masserot C, Peffault de Latour R, Rocha V,
Leblanc T, Rigolet A, Pascal F, Janin A, Soulier J, Gluckman E and
Socié G: Head and neck squamous cell carcinoma in 13 patients with
Fanconi anemia after hematopoietic stem cell transplantation.
Cancer. 113:3315–3322. 2008.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Montanuy H, Martínez-Barriocanal Á,
Antonio Casado J, Rovirosa L, Ramírez MJ, Nieto R, Carrascoso-Rubio
C, Riera P, González A, Lerma E, et al: Gefitinib and Afatinib Show
Potential Efficacy for Fanconi Anemia-Related Head and Neck Cancer.
Clin Cancer Res. 26:3044–3057. 2020.PubMed/NCBI View Article : Google Scholar
|
|
51
|
de Jong EM, Felix JF, de Klein A and
Tibboel D: Etiology of esophageal atresia and tracheoesophageal
fistula: ‘mind the gap’. Curr Gastroenterol Rep. 12:215–222.
2010.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Beauregard-Lacroix E, Tardif J, Lemyre E,
Kibar Z, Faure C and Campeau PM: Genetic Testing in a Cohort of
Complex Esophageal Atresia. Mol Syndromol. 8:236–243.
2017.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Wegman-Ostrosky T and Savage SA: The
genomics of inherited bone marrow failure: From mechanism to the
clinic. Br J Haematol. 177:526–542. 2017.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Clinton C and Gazda HT: Diamond-Blackfan
Anemia. In: GeneReviews®. Adam MP, Ardinger HH, Pagon
RA, et al (eds). University of Washington, Seattle, WA,
2009.
|
|
55
|
Shaikh H and Mewawalla P: Evans Syndrome.
In: StatPearls. StatPearls Publishing, Treasure Island, FL,
2021.
|
|
56
|
Jameson-Lee M, Chen K, Ritchie E, Shore T,
Al-Khattab O and Gergis U: Acute myeloid leukemia in a patient with
thrombocytopenia with absent radii: A case report and review of the
literature. Hematol Oncol Stem Cell Ther. 11:245–247.
2018.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Solomon BD: VACTERL/VATER Association.
Orphanet J Rare Dis. 6(56)2011.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Van Maldergem L, Piard J, Larizza L and
Wang LL: Baller-Gerold Syndrome. In: GeneReviews®. Adam
MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G and
Amemiya A (eds). University of Washington, Seattle, WA, 2007.
|
|
59
|
Kallen ME, Dulau-Florea A, Wang W and
Calvo KR: Acquired and germline predisposition to bone marrow
failure: Diagnostic features and clinical implications. Semin
Hematol. 56:69–82. 2019.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Gluckman E, Devergie A, Schaison G, Bussel
A, Berger R, Sohier J and Bernard J: Bone marrow transplantation in
Fanconi anaemia. Br J Haematol. 45:557–564. 1980.PubMed/NCBI
|
|
61
|
Oostra AB, Nieuwint AW, Joenje H and de
Winter JP: Diagnosis of fanconi anemia: Chromosomal breakage
analysis. Anemia. 2012(238731)2012.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Auerbach AD: Diagnosis of Fanconi anemia
by diepoxybutane analysis. Curr Protoc Hum Genet. 85:8.7.1–8.7.17.
2015.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Esmer C, Sánchez S, Ramos S, Molina B,
Frias S and Carnevale A: DEB test for Fanconi anemia detection in
patients with atypical phenotypes. Am J Med Genet A. 124A:35–39.
2004.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Castella M, Pujol R, Callén E, Ramírez MJ,
Casado JA, Talavera M, Ferro T, Muñoz A, Sevilla J, Madero L, et
al: Chromosome fragility in patients with Fanconi anaemia:
Diagnostic implications and clinical impact. J Med Genet.
48:242–250. 2011.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Fargo JH, Rochowski A, Giri N, Savage SA,
Olson SB and Alter BP: Comparison of chromosome breakage in
non-mosaic and mosaic patients with Fanconi anemia, relatives, and
patients with other inherited bone marrow failure syndromes.
Cytogenet Genome Res. 144:15–27. 2014.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Revy P, Kannengiesser C and Fischer A:
Somatic genetic rescue in Mendelian haematopoietic diseases. Nat
Rev Genet. 20:582–598. 2019.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Nicoletti E, Rao G, Bueren JA, Río P,
Navarro S, Surrallés J, Choi G and Schwartz JD: Mosaicism in
Fanconi anemia: Concise review and evaluation of published cases
with focus on clinical course of blood count normalization. Ann
Hematol. 99:913–924. 2020.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Flynn EK, Kamat A, Lach FP, Donovan FX,
Kimble DC, Narisu N, Sanborn E, Boulad F, Davies SM, Gillio AP III,
et al: Comprehensive analysis of pathogenic deletion variants in
Fanconi anemia genes. Hum Mutat. 35:1342–1353. 2014.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Castella M, Pujol R, Callén E, Trujillo
JP, Casado JA, Gille H, Lach FP, Auerbach AD, Schindler D, Benítez
J, et al: Origin, functional role, and clinical impact of Fanconi
anemia FANCA mutations. Blood. 117:3759–3769. 2011.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Bogliolo M, Pujol R, Aza-Carmona M,
Muñoz-Subirana N, Rodriguez-Santiago B, Casado JA, Rio P, Bauser C,
Reina-Castillón J, Lopez-Sanchez M, et al: Optimised molecular
genetic diagnostics of Fanconi anaemia by whole exome sequencing
and functional studies. J Med Genet. 57:258–268. 2020.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Frohnmayer L, Van Ravenhorst S and
Wirkkula L (eds): Fanconi anemia Clinical Care Guidelines. 5th
edition. Fanconi Anemia Research Fund, Eugene, OR, 2020.
|
|
72
|
Rosenberg PS, Huang Y and Alter BP:
Individualized risks of first adverse events in patients with
Fanconi anemia. Blood. 104:350–355. 2004.PubMed/NCBI View Article : Google Scholar
|
|
73
|
de Winter JP and Joenje H: The genetic and
molecular basis of Fanconi anemia. Mutat Res. 668:11–19.
2009.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Wang X, Andreassen PR and D'Andrea AD:
Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1
in chromatin. Mol Cell Biol. 24:5850–5862. 2004.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Lobitz S and Velleuer E: Guido Fanconi
(1892-1979): A jack of all trades. Nat Rev Cancer. 6:893–898.
2006.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Sasaki MS and Tonomura A: A high
susceptibility of Fanconi's anemia to chromosome breakage by DNA
cross-linking agents. Cancer Res. 33:1829–1836. 1973.PubMed/NCBI
|
